Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Change in Receivables (2016 - 2026)

Healthequity has reported Change in Receivables over the past 14 years, most recently at $12.5 million for Q1 2026.

  • Quarterly results put Change in Receivables at $12.5 million for Q1 2026, up 10.26% from a year ago — trailing twelve months through Jan 2026 was $5.7 million (down 56.61% YoY), and the annual figure for FY2026 was $5.7 million, down 56.61%.
  • Change in Receivables for Q1 2026 was $12.5 million at Healthequity, up from $79000.0 in the prior quarter.
  • Over the last five years, Change in Receivables for HQY hit a ceiling of $12.5 million in Q1 2026 and a floor of -$5.8 million in Q3 2023.
  • Median Change in Receivables over the past 5 years was $1.3 million (2024), compared with a mean of $2.2 million.
  • Peak annual rise in Change in Receivables hit 1971.84% in 2022, while the deepest fall reached 400.0% in 2022.
  • Healthequity's Change in Receivables stood at -$2.7 million in 2022, then soared by 232.84% to $3.6 million in 2023, then plummeted by 148.39% to -$1.7 million in 2024, then soared by 104.54% to $79000.0 in 2025, then surged by 15663.29% to $12.5 million in 2026.
  • The last three reported values for Change in Receivables were $12.5 million (Q1 2026), $79000.0 (Q4 2025), and -$5.1 million (Q3 2025) per Business Quant data.